Current Status of siRNA Delivery Technology and siRNA Drug Development

T. Urakami, N. Oku
{"title":"Current Status of siRNA Delivery Technology and siRNA Drug Development","authors":"T. Urakami, N. Oku","doi":"10.2174/1874126600701010020","DOIUrl":null,"url":null,"abstract":"In the past decade, therapeutic potential of RNA interference (RNAi) and its application to human diseases were widely discussed in the related fields of biology, medical sciences, and pharmaceutical sciences. In course of these research and developing processes, efficient transduction of small interfering RNA (siRNA) into target cells is one of the most significant breakthroughs in revealing the feasibility of siRNA-mediated therapies. From the aspect of new siRNA derived drug development, drug delivery system (DDS) holds the key to success. Many studies in the field of DDS have revealed the principles of administration, distribution, metabolism, and excretion of drug carriers in living bodies. Fur- thermore, these principles put ideas of the theoretical formulation adapted to use in local and systemic administration of siRNA. In this review we focused on the current technology of DDS and its importance upon realizing the therapeutic use of siRNA.","PeriodicalId":421840,"journal":{"name":"The Open Drug Delivery Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2007-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Drug Delivery Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874126600701010020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

In the past decade, therapeutic potential of RNA interference (RNAi) and its application to human diseases were widely discussed in the related fields of biology, medical sciences, and pharmaceutical sciences. In course of these research and developing processes, efficient transduction of small interfering RNA (siRNA) into target cells is one of the most significant breakthroughs in revealing the feasibility of siRNA-mediated therapies. From the aspect of new siRNA derived drug development, drug delivery system (DDS) holds the key to success. Many studies in the field of DDS have revealed the principles of administration, distribution, metabolism, and excretion of drug carriers in living bodies. Fur- thermore, these principles put ideas of the theoretical formulation adapted to use in local and systemic administration of siRNA. In this review we focused on the current technology of DDS and its importance upon realizing the therapeutic use of siRNA.
siRNA传递技术及siRNA药物开发现状
在过去的十年中,RNA干扰(RNAi)的治疗潜力及其在人类疾病中的应用在生物学、医学和药学等相关领域得到了广泛的讨论。在这些研究和开发过程中,小干扰RNA (small interfering RNA, siRNA)高效转导到靶细胞是揭示siRNA介导治疗可行性的最重要突破之一。从新型siRNA衍生药物开发的角度来看,药物传递系统(DDS)是成功的关键。DDS领域的许多研究揭示了药物载体在生物体内的给药、分布、代谢和排泄的原理。此外,这些原则提出了适用于siRNA局部和系统管理的理论构想。在这篇综述中,我们重点介绍了DDS技术的现状及其在实现siRNA治疗应用中的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信